Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2309]

Shortening the timeline for clinical drug developments

Dr James Doroshow – National Cancer Institute, Bethesda, USA

Shortening the timeline for clinical drug developments ( Dr James Doroshow – National Cancer Institute, Bethesda, USA )

Building international collaborations and the WINTHER trial

Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA

Building international collaborations and the WINTHER trial ( Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA )

Addressing the problem of adherence to treatment

Giora Sharf – Israeli CML Patients Support Group

Addressing the problem of adherence to treatment ( Giora Sharf – Israeli CML Patients Support Group )

Patient and doctor communication and quality of life guidelines

Jan Geissler – CML Advocates Network

Patient and doctor communication and quality of life guidelines ( Jan Geissler – CML Advocates Network )

President's overview of ASCO 2012

Dr Michael Link - Stanford School of Medicine, California, USA

President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )

Drug shortage impact on cancer care and efforts to resolve the issue

Dr Sandra Kweder - US Food and Drug Administration

Drug shortage impact on cancer care and efforts to resolve the issue ( Dr Sandra Kweder - US Food and Drug Administration )

Patient perspective on drug shortages

Dr Michael Link - Stanford University School of Medicine, California, USA

Patient perspective on drug shortages ( Dr Michael Link - Stanford University School of Medicine, California, USA )

Recommendations for averting drug shortages

Dr Richard Schilsky - University of Chicago, USA

Recommendations for averting drug shortages ( Dr Richard Schilsky - University of Chicago, USA )

FDA's comments on drug shortages

Dr Charles Penley - Tennessee Oncology, USA

FDA's comments on drug shortages ( Dr Charles Penley - Tennessee Oncology, USA )

Lower-income Patients are less likely to participate in clinical trials

Dr Joseph Unger - SWOG Statistical Center, Seattle, USA

Lower-income Patients are less likely to participate in clinical trials ( Dr Joseph Unger - SWOG Statistical Center, Seattle, USA )

The Institute of Cancer Policy

Prof Richard Sullivan – Kings College, London, UK

The Institute of Cancer Policy ( Prof Richard Sullivan – Kings College, London, UK )

Analysing changes in the pharmaceutical industry

Dr Siegfried Bialojan – Ernst and Young, Germany

Analysing changes in the pharmaceutical industry ( Dr Siegfried Bialojan – Ernst and Young, Germany )

More from ecancer